A key factoror lack thereofin this is the pharmaceutical companies, which are not exactly jumping on board to fund these very expensive studies
Abstract Introduction GLP-1 receptor agonists (GLP1-RAs) are increasingly prescribed as an alternative to bariatric surgery for weight loss, and may pose as an alternative to conversion Roux-En-Y Gastric Bypass (cRYGB) in patients with insufficient weight loss or weight recurrence after sleeve gastrectomy [A C, N C, A I
doi: 10.1111/dom.12824 [DOI] [PubMed] [Google Scholar] 44
Antioxidant supplementation may be effective in controlling the production of ROS and continues to be explored as a potential strategy to overcome reproductive disorders associated with infertility
In July 2023, the FDA announced it was reviewing reports of stomach paralysis associated with GLP-1 drugs, including Ozempic and Wegovy
However, many people taking medications notice some differences in urine color, even if the drug itself isnt known to cause it